John P. Sharp
2011 - Ligand Pharmaceuticals
In 2011, John P. Sharp earned a total compensation of $597K as Former VP, Finance and Chief Financial Officer at Ligand Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $106,003 |
|---|---|
| Option Awards | $192,555 |
| Salary | $265,007 |
| Stock Awards | $30,150 |
| Other | $3,284 |
| Total | $596,999 |
Sharp received $265K in salary, accounting for 44% of the total pay in 2011.
Sharp also received $106K in non-equity incentive plan, $192.6K in option awards, $30.2K in stock awards and $3.3K in other compensation.
Rankings
In 2011, John P. Sharp's compensation ranked 7,505th out of 10,747 executives tracked by ExecPay. In other words, Sharp earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,505 out of 10,747 | 30th |
Division Manufacturing | 2,752 out of 3,960 | 31st |
Major group Chemicals And Allied Products | 680 out of 1,033 | 34th |
Industry group Drugs | 476 out of 781 | 39th |
Industry Pharmaceutical Preparations | 368 out of 571 | 36th |
Source: SEC filing on April 21, 2014.
Sharp's colleagues
We found three more compensation records of executives who worked with John P. Sharp at Ligand Pharmaceuticals in 2011.